Epogen and Aranesp.Epogen E·po·gen A trademark for the drug epoetin alfa. epoetin alfa Epogen, Eprex (CA) (UK), Procrit Pharmacologic class: Recombinant human erythropoietin Therapeutic class: and Aranesp: A court date is set for next November November: see month. in the copyright suit filed by drug maker Amgen Inc. that alleged Swiss drug maker and competitor Roche n. 1. Rock. copied its anemia anemia (ənē`mēə), condition in which the concentration of hemoglobin in the circulating blood is below normal. Such a condition is caused by a deficient number of erythrocytes (red blood cells), an abnormally low level of hemoglobin drugs Epogen and Aranesp to create a new drug, Mircera. Amgen is asking that the government not allow the drug to be imported to the states. If Amgen loses the case, it could make Mircera a major competitor to Amgen, which has had the anemia treatment market cornered for years. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion